Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression

Authors:

Abstract
Quiz Ref ID Up to one-third of individuals with depression develop a chronic course of more than 2 years of depression, with an estimated lifetime prevalence between 3% and 6%.1,2 Compared with acute depression, chronic forms are characterized by greater comorbidity and more impaired social function and physical health, as well as more frequent suicide attempts and hospitalizations.3,4 Moreover, this patient group benefits less from psychological and pharmaceutical treatment compared with patients with acute episodic depression,5,6 or they need higher dosages of medication and a longer duration of treatment to improve.7 The only specific psychotherapy that has been tailored for early-onset chronic depression is the Cognitive Behavioral Analysis System of Psychotherapy (CBASP),8 which fared equally well as medication and significantly increased efficacy when added to treatment with antidepressants.9-11 In a subgroup of patients with chronic depression and childhood trauma, CBASP outperformed medication regarding rates of remission.12 As an augmentation strategy, 12 weeks of CBASP did not lead to better results than augmentation with supportive psychotherapy (SP) or switching medication in patients with chronic depression who did not respond or partially responded to medication.13 However, those results must be interpreted with caution since prior investigations suggest that a longer duration of treatment is necessary for symptom improvement in this patient group.7,14 In addition to the need to evaluate a longer-term application of CBASP, the approach was never compared as first-line treatment vs nonspecific psychotherapy or a pharmacologic placebo condition. Only indirect evidence from a network meta-analysis is available suggesting that CBASP is likely to outperform nonspecific treatments.10

This publication has 21 references indexed in Scilit: